Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity

Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity

US Patent 11408000 · Granted Aug 9, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for the treatment of trinucleotide repeat expansion disorders associated2025
Methods for the treatment of trinucleotide repeat expansion disorders associated2025
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
RNA-editing oligonucleotides and uses thereof2025
Oligonucleotides for the treatment of nucleotide repeat expansion disorders asso2025
Oligonucleotides for the treatment of nucleotide repeat expansion disorders asso2025
Oligonucleotides for the treatment of nucleotide repeat expansion disorders asso2025
RNA-editing oligonucleotides and uses thereof2024
RNA-editing oligonucleotides and uses thereof2024
SERPINA1 iRNA compositions and methods of use thereof2024
RNA-editing oligonucleotides and uses thereof2024
Complement component C5 iRNA compositions and methods of use thereof2024